Skip to content

Antonina Naskalska

Antonina Naskalska, Ph.D.
Researcher
Laboratory of Virology MCB
E-mail: Antonina.Naskalska [AT] uj.edu.pl

Research interests

  • Virus like particles and viral vectors

Education & Experience
Show More

    • 23.02.2010: PhD dissertation
    • 2006-2010: PhD studies, School of Molecular Biology, Institute of Biochemistry of the Polish Academy of Sciences
    • 2005-2006: Marie Curie research fellow, Institut de Biologie Structurale, Grenoble, France
    • 2004-2005: post-graduate studies - Cell Biology University of Joseph Fourier, Grenoble, France
    • 1999-2004: Medical Analytics, Faculty of Pharmacy, Medical College of the Jagiellonian University, Krakow, Poland (MSc studies)

    1. Zabieglo K, Majewski P, Majchrzak-Gorecka M, Wlodarczyk A, Grygier B, Zegar A, Kapinska-Mrowiecka M, Naskalska A, Pyrc K, Dubin A, Wahl S, Cichy J#. (2015). The inhibitory effect of secretory leukocyte protease inhibitor (SLPI) on formation of neutrophil extracellular traps. Journal of Leukocyte Biology. In press.
    2. Naskalska A, Pyrc K#. (2015) Virus Like Particles as Immunogens and Universal Nanocarriers. Polish Journal of Microbiology. 64(1):3-13.
    3. Naskalska A, Szolajska E, Andreev I, Podsiadla M, Chroboczek J. Towards a novel influenza vaccine: engineering of hemagglutinin on a platform of adenovirus dodecahedron. BMC Biotechnol. 2013 16;13:50.
    4. Szolajska E, Burmeister WP, Zochowska M, Nerlo B, Andreev I, Schoehn G, Andrieu JP, Fender P, Naskalska A, Zubieta C, Cusack S, Chroboczek J. 2012. The structural basis for the integrity of adenovirus ad3 dodecahedron. PLoS One. 2012;7(9):e46075.
    5. Naskalska A, Szolajska E, Chaperot L, Angel J, Plumas J, Chroboczek J. 2009. Influenza recombinant vaccine: matrix protein M1 on the platform of the adenovirus dodecahedron. Vaccine. 27(52):7385-93.
    6. Malecki MT, Skupien J, Klupa T, Naskalska A, Gorczynska-Kosiorz S, Moczulski DK, Sieradzki J. 2006. Maternally inherited diabetes with deafness and obesity: body weight reduction response to treatment with insulin analogues. Rev Diabet Stud. 3(4):205-7.